324 related articles for article (PubMed ID: 26640224)
1. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.
Akuzawa K; Yamada R; Li Z; Li Y; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
Antiviral Res; 2011 Sep; 91(3):296-303. PubMed ID: 21745500
[TBL] [Abstract][Full Text] [Related]
3. Anti-cytomegalovirus effects of tricin are dependent on CXCL11.
Murayama T; Li Y; Takahashi T; Yamada R; Matsubara K; Tuchida Y; Li Z; Sadanari H
Microbes Infect; 2012 Oct; 14(12):1086-92. PubMed ID: 22683667
[TBL] [Abstract][Full Text] [Related]
4. An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
Fujimoto KJ; Nema D; Ninomiya M; Koketsu M; Sadanari H; Takemoto M; Daikoku T; Murayama T
Antiviral Res; 2018 Jun; 154():10-16. PubMed ID: 29559264
[TBL] [Abstract][Full Text] [Related]
5. Tricin inhibits the CCL5 induction required for efficient growth of human cytomegalovirus.
Itoh A; Sadanari H; Takemoto M; Matsubara K; Daikoku T; Murayama T
Microbiol Immunol; 2018 May; 62(5):341-347. PubMed ID: 29603339
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human cytomegalovirus replication by tricin is associated with depressed CCL2 expression.
Akai Y; Sadanari H; Takemoto M; Uchide N; Daikoku T; Mukaida N; Murayama T
Antiviral Res; 2017 Dec; 148():15-19. PubMed ID: 28965916
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).
Murayama T; Yamaguchi N; Iwamoto K; Eizuru Y
Antivir Chem Chemother; 2006; 17(1):11-6. PubMed ID: 16542001
[TBL] [Abstract][Full Text] [Related]
8. Anti-human cytomegalovirus activity of constituents from Sasa albo-marginata (Kumazasa in Japan).
Sakai A; Watanabe K; Koketsu M; Akuzawa K; Yamada R; Li Z; Sadanari H; Matsubara K; Muroyama T
Antivir Chem Chemother; 2008; 19(3):125-32. PubMed ID: 19024629
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
[TBL] [Abstract][Full Text] [Related]
10. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
Bhave S; Elford H; McVoy MA
Antiviral Res; 2013 Oct; 100(1):151-8. PubMed ID: 23933116
[TBL] [Abstract][Full Text] [Related]
12. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
[TBL] [Abstract][Full Text] [Related]
17. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
18. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir.
Hamzeh FM; Spector T; Lietman PS
Antimicrob Agents Chemother; 1993 Mar; 37(3):602-4. PubMed ID: 8384821
[TBL] [Abstract][Full Text] [Related]
19. Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
Drouot E; Piret J; Boivin G
Antivir Ther; 2016; 21(6):535-539. PubMed ID: 26844400
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
